These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 27899401

  • 1. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D, Brownell M, Chateau D, Ruth C, Katz LY.
    BMJ Open; 2016 Nov 29; 6(11):e013293. PubMed ID: 27899401
    [Abstract] [Full Text] [Related]

  • 2. Infant and childhood neurodevelopmental outcomes following prenatal exposure to selective serotonin reuptake inhibitors: overview and design of a Finnish Register-Based Study (FinESSI).
    Malm H, Artama M, Brown AS, Gissler M, Gyllenberg D, Hinkka-Yli-Salomäki S, McKeague I, Sourander A.
    BMC Psychiatry; 2012 Dec 04; 12():217. PubMed ID: 23206294
    [Abstract] [Full Text] [Related]

  • 3. Prenatal Antidepressant Exposure and Offspring Brain Morphologic Trajectory.
    Koc D, Tiemeier H, Stricker BH, Muetzel RL, Hillegers M, El Marroun H.
    JAMA Psychiatry; 2023 Dec 01; 80(12):1208-1217. PubMed ID: 37647036
    [Abstract] [Full Text] [Related]

  • 4. Rate of Chiari I malformation in children of mothers with depression with and without prenatal SSRI exposure.
    Knickmeyer RC, Meltzer-Brody S, Woolson S, Hamer RM, Smith JK, Lury K, Gilmore JH.
    Neuropsychopharmacology; 2014 Oct 01; 39(11):2611-21. PubMed ID: 24837031
    [Abstract] [Full Text] [Related]

  • 5. Maternal treatment with selective serotonin reuptake inhibitors during pregnancy and delayed neonatal adaptation: a population-based cohort study.
    Cornet MC, Wu YW, Forquer H, Avalos LA, Sriram A, Scheffler AW, Newman TB, Kuzniewicz MW.
    Arch Dis Child Fetal Neonatal Ed; 2024 Apr 18; 109(3):294-300. PubMed ID: 38071585
    [Abstract] [Full Text] [Related]

  • 6. Antidepressant use in pregnancy and the risk of cardiac defects.
    Huybrechts KF, Palmsten K, Avorn J, Cohen LS, Holmes LB, Franklin JM, Mogun H, Levin R, Kowal M, Setoguchi S, Hernández-Díaz S.
    N Engl J Med; 2014 Jun 19; 370(25):2397-407. PubMed ID: 24941178
    [Abstract] [Full Text] [Related]

  • 7. Selective Serotonin Reuptake Inhibitors (SSRIs) in Pregnancy: An Updated Review on Risks to Mother, Fetus, and Child.
    Lebin LG, Novick AM.
    Curr Psychiatry Rep; 2022 Nov 19; 24(11):687-695. PubMed ID: 36181572
    [Abstract] [Full Text] [Related]

  • 8. Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects.
    Anderson KN, Lind JN, Simeone RM, Bobo WV, Mitchell AA, Riehle-Colarusso T, Polen KN, Reefhuis J.
    JAMA Psychiatry; 2020 Dec 01; 77(12):1246-1255. PubMed ID: 32777011
    [Abstract] [Full Text] [Related]

  • 9. Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception.
    Weikum WM, Oberlander TF, Hensch TK, Werker JF.
    Proc Natl Acad Sci U S A; 2012 Oct 16; 109 Suppl 2(Suppl 2):17221-7. PubMed ID: 23045665
    [Abstract] [Full Text] [Related]

  • 10. Prenatal antidepressant use and risk of congenital malformations: A population-based cohort study.
    Chan JKN, Lee KCK, Wong CSM, Chang WC.
    Psychiatry Res; 2024 Sep 16; 339():116038. PubMed ID: 38889560
    [Abstract] [Full Text] [Related]

  • 11. Maternal SSRI use during pregnancy and offspring depression or anxiety disorders: A review of the literature and description of a study protocol for a register-based cohort study.
    Upadhyaya S, Brown A, Cheslack-Postava K, Gissler M, Gyllenberg D, Heinonen E, Laitinen J, McKeague I, Hinkka-Yli-Salomäki S, Sourander A, Tornio A, Malm H.
    Reprod Toxicol; 2023 Jun 16; 118():108365. PubMed ID: 36958464
    [Abstract] [Full Text] [Related]

  • 12. Long-Term Effects of Intrauterine Exposure to Antidepressants on Physical, Neurodevelopmental, and Psychiatric Outcomes: A Systematic Review.
    Rommel AS, Bergink V, Liu X, Munk-Olsen T, Molenaar NM.
    J Clin Psychiatry; 2020 May 12; 81(3):. PubMed ID: 32412703
    [Abstract] [Full Text] [Related]

  • 13. Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States.
    Palmsten K, Hernández-Díaz S, Huybrechts KF, Williams PL, Michels KB, Achtyes ED, Mogun H, Setoguchi S.
    BMJ; 2013 Aug 21; 347():f4877. PubMed ID: 23965506
    [Abstract] [Full Text] [Related]

  • 14. Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors.
    Smith MV, Sung A, Shah B, Mayes L, Klein DS, Yonkers KA.
    Early Hum Dev; 2013 Feb 21; 89(2):81-6. PubMed ID: 22999988
    [Abstract] [Full Text] [Related]

  • 15. Timing of selective serotonin reuptake inhibitor use and risk for preterm birth and related adverse events: with a consideration of the COVID-19 pandemic period.
    Hwang YM, Roper RT, Piekos SN, Enquobahrie DA, Hebert MF, Paquette AG, Baloni P, Price ND, Hood L, Hadlock JJ.
    J Matern Fetal Neonatal Med; 2024 Dec 21; 37(1):2313364. PubMed ID: 38342572
    [Abstract] [Full Text] [Related]

  • 16. Antidepressant use in pregnancy: a critical review focused on risks and controversies.
    Byatt N, Deligiannidis KM, Freeman MP.
    Acta Psychiatr Scand; 2013 Feb 21; 127(2):94-114. PubMed ID: 23240634
    [Abstract] [Full Text] [Related]

  • 17. Behavioural effects of fetal antidepressant exposure in a Norwegian cohort of discordant siblings.
    Brandlistuen RE, Ystrom E, Eberhard-Gran M, Nulman I, Koren G, Nordeng H.
    Int J Epidemiol; 2015 Aug 21; 44(4):1397-407. PubMed ID: 25873178
    [Abstract] [Full Text] [Related]

  • 18. Intrauterine Exposure to Antidepressants or Maternal Depressive Symptoms and Offspring Brain White Matter Trajectories From Late Childhood to Adolescence.
    Koc D, El Marroun H, Stricker BH, Muetzel RL, Tiemeier H.
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 Feb 21; 9(2):217-226. PubMed ID: 37926188
    [Abstract] [Full Text] [Related]

  • 19. Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes.
    Santucci AK, Singer LT, Wisniewski SR, Luther JF, Eng HF, Dills JL, Sit DK, Hanusa BH, Wisner KL.
    J Clin Psychiatry; 2014 Oct 21; 75(10):1088-95. PubMed ID: 25373117
    [Abstract] [Full Text] [Related]

  • 20. Maternal serotonin: implications for the use of selective serotonin reuptake inhibitors during gestation†.
    Domingues RR, Wiltbank MC, Hernandez LL.
    Biol Reprod; 2023 Jul 11; 109(1):17-28. PubMed ID: 37098165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.